Multi‐functional liposome: a powerful theranostic nano‐platform enhancing photodynamic therapy
X Cheng, J Gao, Y Ding, Y Lu, Q Wei, D Cui… - Advanced …, 2021 - Wiley Online Library
Although photodynamic therapy (PDT) has promising advantages in almost non‐invasion,
low drug resistance, and low dark toxicity, it still suffers from limitations in the lipophilic …
low drug resistance, and low dark toxicity, it still suffers from limitations in the lipophilic …
Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment
J Bariwal, H Ma, GA Altenberg, H Liang - Chemical Society Reviews, 2022 - pubs.rsc.org
Cancer therapy is a significant challenge due to insufficient drug delivery to the cancer cells
and non-selective killing of healthy cells by most chemotherapy agents. Nano-formulations …
and non-selective killing of healthy cells by most chemotherapy agents. Nano-formulations …
Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles
The translational success of liposomes in chemotherapeutics has already demonstrated the
great potential of biomembrane-based nanostructure in effective drug delivery. Meanwhile …
great potential of biomembrane-based nanostructure in effective drug delivery. Meanwhile …
Recent advancements in polymer/liposome assembly for drug delivery: From surface modifications to hybrid vesicles
Liposomes are consolidated and attractive biomimetic nanocarriers widely used in the field
of drug delivery. The structural versatility of liposomes has been exploited for the …
of drug delivery. The structural versatility of liposomes has been exploited for the …
Updates on responsive drug delivery based on liposome vehicles for cancer treatment
MP Nikolova, EM Kumar, MS Chavali - Pharmaceutics, 2022 - mdpi.com
Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …
Organ‐on‐a‐chip: A preclinical microfluidic platform for the progress of nanomedicine
RO Rodrigues, PC Sousa, J Gaspar, M Bañobre‐López… - Small, 2020 - Wiley Online Library
Despite the progress achieved in nanomedicine during the last decade, the translation of
new nanotechnology‐based therapeutic systems into clinical applications has been slow …
new nanotechnology‐based therapeutic systems into clinical applications has been slow …
Stimulus-responsive liposomes for biomedical applications
AI Antoniou, S Giofrè, P Seneci, D Passarella… - Drug discovery today, 2021 - Elsevier
Liposomes are amphipathic lipidic supramolecular aggregates that are able to encapsulate
and carry molecules of both hydrophilic and hydrophobic nature. They have been widely …
and carry molecules of both hydrophilic and hydrophobic nature. They have been widely …
Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment
Highlights•Mitochondria are involved in various physiochemical and biochemical
processes.•Owing to their crucial role in cellular metabolism, mitochondria are favored …
processes.•Owing to their crucial role in cellular metabolism, mitochondria are favored …
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) are amongst
the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic …
the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic …
An update on actively targeted liposomes in advanced drug delivery to glioma
S Mojarad-Jabali, M Farshbaf, PR Walker… - International Journal of …, 2021 - Elsevier
High-grade glioma is one of the most aggressive types of cancer with a low survival rate
ranging from 12 to 15 months after the first diagnosis. Though being the most common …
ranging from 12 to 15 months after the first diagnosis. Though being the most common …